Schedule 13D ownership disclosure

EYEPOINT PHARMACEUTICALS INC

Security class unavailable · CUSIP: 30233G100

Event date: 2023-12-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-291815
Form type
SC 13D/A
Filer
EW Healthcare Partners, L.P.
CIK
CIK 1612343
Filed
Dec 08, 2023
Reporting period
Dec 04, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub